新芝生物
(920685)
| 流通市值：0.00万 | | | 总市值：0.00万 |
| 流通股本：0.00万 | | | 总股本：0.00万 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 71,149,555.52 | 32,661,264.97 | 168,092,009.31 | 108,698,472.95 |
| 营业收入 | 71,149,555.52 | 32,661,264.97 | 168,092,009.31 | 108,698,472.95 |
| 二、营业总成本 | 58,867,387.47 | 26,613,381.96 | 132,795,178.43 | 90,655,525.72 |
| 营业成本 | 26,694,563.99 | 12,009,120.34 | 64,652,854.66 | 40,868,995.03 |
| 税金及附加 | 1,061,638.04 | 502,673.84 | 2,345,238.14 | 1,138,768.81 |
| 销售费用 | 11,713,804.14 | 5,284,626.37 | 26,000,545.47 | 16,923,633.69 |
| 管理费用 | 11,428,371.85 | 5,523,560.17 | 23,863,703.1 | 19,064,108.49 |
| 研发费用 | 8,481,346.28 | 3,658,992.32 | 17,738,026.42 | 14,030,100.63 |
| 财务费用 | -512,336.83 | -365,591.08 | -1,805,189.36 | -1,370,080.93 |
| 其中:利息费用 | 83,611.51 | 35,331.88 | 186,244.42 | 148,495.44 |
| 其中:利息收入 | 553,886.56 | 336,645.82 | 1,973,190.46 | 1,492,288.54 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,598,663.34 | 762,343.28 | 3,163,765.13 | 2,266,077.09 |
| 加:投资收益 | 1,125,535.31 | 651,636.68 | 2,752,930.97 | 2,121,489.2 |
| 资产处置收益 | - | -9,174.31 | 13,680,415.14 | 23,875.22 |
| 资产减值损失(新) | -1,298,986.72 | -375,171.49 | -1,804,158.47 | -1,304,297.58 |
| 信用减值损失(新) | -77,260.5 | 18,925.9 | -187,502.97 | -377,004.2 |
| 其他收益 | 2,847,509.8 | 1,789,123.48 | 6,464,302.4 | 5,262,788.33 |
| 四、营业利润 | 16,477,629.28 | 8,885,566.55 | 59,366,583.08 | 26,035,875.29 |
| 加:营业外收入 | 45,254.81 | 45,253.19 | 1,009,708.79 | 1,009,706.17 |
| 减:营业外支出 | 13,543.67 | 723.39 | 569,560.8 | 196,966.36 |
| 五、利润总额 | 16,509,340.42 | 8,930,096.35 | 59,806,731.07 | 26,848,615.1 |
| 减:所得税费用 | 1,364,738.36 | 1,047,870.65 | 8,159,700.9 | 2,752,158.94 |
| 六、净利润 | 15,144,602.06 | 7,882,225.7 | 51,647,030.17 | 24,096,456.16 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 15,144,602.06 | 7,882,225.7 | 51,647,030.17 | 24,096,456.16 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 11,865,551.27 | 6,501,584.76 | 41,627,687.27 | 21,653,091.07 |
| 少数股东损益 | 3,279,050.79 | 1,380,640.94 | 10,019,342.9 | 2,443,365.09 |
| 扣除非经常损益后的净利润 | 8,928,793.43 | 4,994,111.52 | 28,264,779.43 | 15,723,537.82 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.13 | 0.07 | 0.47 | 0.24 |
| (二)稀释每股收益 | 0.13 | 0.07 | 0.47 | 0.24 |
| 九、综合收益总额 | 15,144,602.06 | 7,882,225.7 | 51,647,030.17 | 24,096,456.16 |
| 归属于母公司股东的综合收益总额 | 11,865,551.27 | 6,501,584.76 | 41,627,687.27 | 21,653,091.07 |
| 归属于少数股东的综合收益总额 | 3,279,050.79 | 1,380,640.94 | 10,019,342.9 | 2,443,365.09 |
| 公告日期 | 2025-08-26 | 2025-04-28 | 2025-04-21 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |